本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Avidity Biosciences, Inc.

49.94
+1.473.02%
成交量:241.13萬
成交額:1.21億
市值:64.24億
市盈率:-14.00
高:51.39
開:49.07
低:48.37
收:48.47
52周最高:56.00
52周最低:21.51
股本:1.29億
流通股本:9,981.53萬
量比:1.32
換手率:2.42%
股息:- -
股息率:- -
每股收益(TTM):-3.5671
每股收益(LYR):-2.8885
淨資產收益率:-37.76%
總資產收益率:-24.01%
市淨率:5.39
市盈率(LYR):-17.29

資料載入中...

2024/06/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/12

重要事件披露

Form 8-K - Current report
2024/06/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/15

重要事件披露

Form 8-K - Current report
2024/05/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/06

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/04

重要事件披露

Form 8-K - Current report
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/01

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans